Caditraz 2.5mg Tablet

Caditraz 2.5mg is an anti-cancer medication that belongs to the aromatase inhibitor class. It is indicated as adjuvant therapy following primary treatment or as first-line therapy for postmenopausal women with early and advanced breast cancer whose tumours are hormone receptor-positive. Since elevated oestrogen levels are associated with breast cancer development, this medicine reduces female reproductive hormone levels by inhibiting the aromatase enzyme responsible for oestrogen production. This medicine aims to slow or stop tumour growth and/or spread to other body sites. Inform your doctor if you have not yet attained menopause, as this medicine is not effective for premenopausal women. Since this medicine lowers female reproductive hormone levels, it is not recommended for menstruating women due to associated fertility concerns. It is advised to monitor your cholesterol levels, as this medicine may elevate cholesterol. This medicine may also decrease bone mineral density. Therefore, discuss with your doctor and consider regular monitoring of bone parameters. Effective contraception is advised during treatment and for at least 3 weeks after the final dose because Caditraz 2.5mg can cause when administrated.

First and second-line treatment of postmenopausal women with hormone receptor-positive breast cancer. Supportive to standard treatment for postmenopausal women with early breast cancer. Treatment for unknown advanced breast cancer in postmenopausal women. Extended supportive therapy for postmenopausal women with early breast cancer who have already taken other anti-cancer medication.

The growth of some cancers in breasts is stimulated by estrogens. Caditraz 2.5mg tablet is a nonsteroidal compound that inhibits estrogen production by blocking the enzyme aromatase. This medicine reduces the tumor size and stops or slows the progression of the disease, avoiding the reoccurring of early-stage breast cancer and improving the survival rate.

Take the Caditraz 2.5mg as your physician advises. Usually, the tablets will be taken with or without food. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the tablet if your doctor advises you to stop.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious Decreased red blood cells Decreased bone mineral density Fluid build up in lungs Common: Swelling in the face, eyes, feet, and legs Hot sweats and excessive sweating Hypercholesterolemia (high cholesterol) Constipation Heart papilation Hypertension Diarrhea Loss of appetite Nausea and Vomiting Muscle pain, bone pain, and joint stiffness Dizziness, tiredness, and sleepiness Breathing difficulty Arthralgia

Notify your doctor if you have hypersensitivity because this medication is contraindicated to such a medical condition. Inform your physician if you have osteoporosis or bone fractures, and periodic monitoring of bone mineral density is required while you are on Caditraz 2.5mg tablet because this medicine can cause a decrease in the bone mineral density. Discuss with your doctor if you are planning for pregnancy, as this medicine shall impact the reproductive potential and might lead to fertility issues. Do not consume this medicine if you are still menstruating and have not yet gone through menopause. Report to your doctor if you are tolerant to any forms of sugar, as Letrozole Tablet contains lactose ingredients. If you missed a dose, do not take a double dose for the forgotten dose. Skip the missed dose and go with a regular schedule.